Ozlo Sleep, a pioneering company dedicated to enhancing sleep quality through science-based audio technology, has successfully raised an impressive $12 million in its latest funding round. With the goal of helping individuals unlock their full potential by improving their sleep hygiene, Ozlo Sleep has developed cutting-edge audio devices known as Ozlo Sleepbuds. These innovative sleepbuds use advanced streaming and sensing technology to create a personalized and calming auditory environment, allowing users to drift into restful slumber and wake feeling rejuvenated. The fresh capital will enable the company to expand its research and development efforts, further refine its product offerings, and accelerate its go-to-market strategies. As part of this exciting announcement, Ozlo Sleep is also live on Kickstarter, inviting backers to be a part of their mission and help bring these next-gen sleep solutions into homes around the globe. This funding milestone not only cements Ozlo Sleep’s position as a leader in the sleep tech industry but also emphasizes the growing recognition of sleep as a critical component of overall well-being. With a dedicated team of experts and cutting-edge technology at its disposal, Ozlo Sleep is set to transform the way people experience rest, ultimately empowering them to awaken to their true potential each day. Join the sleep revolution and learn more about the Ozlo Sleep experience on their Kickstarter page, where securing your own set of Sleepbuds can ignite your journey towards restorative sleep.
Ozlo Sleep Secures $12 Million in Funding to Revolutionize Sleep Technology
Get the full Ozlo Sleep company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today